Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer
-
Stock Symbol
-
ELVN on Nasdaq
Joseph P. Lyssikatos - trading volume in the past year for Enliven Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1.02M |
$30.5M |
$30.00 |
Oct 18, 2024 |
Indirect |
|
|
| Stock Option (right to buy) |
171K |
|
|
Feb 6, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.